$MOBI News

BTIG Reiterates Buy on Mobia Medical, Maintains $19 Price Target

Mobia Medical to Report Third Quarter 2026 Financial Results on November 5, 2026

Mobia Medical Announces Addition of Paired VNS to Updated AHA Stroke Guidelines

Mobia Medical (MOBI) Q2 2026 Earnings Call Transcript

JP Morgan Maintains Overweight on Mobia Medical, Raises Price Target to $17

BTIG Reiterates Buy on Mobia Medical, Maintains $19 Price Target

Mobia Medical Inc (MOBI) (Q2 2026) Earnings Call Highlights: Revenue Surges 102% as IPO Fuels ...

Mobia Medical Q2 Earnings Call Highlights

Mobia Medical Reports Second Quarter 2026 Financial Results

Mobia Medical, Inc. (MOBI) Q2 2026 Earnings Call Transcript

Mobia Medical Sees FY2026 Sales $54.000M-$56.000M vs $53.504M Est

Mobia Medical Q2 EPS $(1.10) Misses $(0.82) Estimate, Sales $13.505M Beat $12.380M Estimate

Mobia Medical to Report Second Quarter 2026 Financial Results on August 11, 2026

Mobia Medical Appoints Reza Zadno, Ph.D., to its Board of Directors

Mobia Medical Announces Publication of Two-Year Data from VNS-REHAB Trial Demonstrating Durable and Continued Stroke Recovery with Vivistim® Paired VNS™ Therapy

Mobia Medical Announces Publication Of 2-Yr Follow-Up Data From VNS-REHAB Study In Neurology, Official Peer-Reviewed Journal Of American Academy Of Neurology

Mobia Medical Announces Vivistim® Procedure Remains Assigned to New Technology APC 1580 under CMS Proposed 2027 Hospital Outpatient Prospective Payment System Rule

Mobia Medical Says CMS Proposes To Maintain Vivistim CPT Code 64568 Under New Technology APC 1580 With ~$45,000 Outpatient Payment Rate For 2027

Mobia Medical Q1 EPS $(19.30) Down From $(12.97) YoY, Sales $12.074M Up From $5.661M YoY

JP Morgan Initiates Coverage On Mobia Medical with Overweight Rating, Announces Price Target of $15